Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 13.99B | 13.95B | 13.60B | 13.34B | 12.36B | 11.60B |
Gross Profit | 6.06B | 6.02B | 5.94B | 5.43B | 4.66B | 4.28B |
EBITDA | 2.23B | 2.19B | 2.17B | 1.81B | 1.77B | 1.57B |
Net Income | 956.00M | 782.00M | 1.02B | 833.00M | 523.00M | 369.60M |
Balance Sheet | ||||||
Total Assets | 29.77B | 29.47B | 29.24B | 26.64B | 25.73B | 25.29B |
Cash, Cash Equivalents and Short-Term Investments | 6.41B | 6.40B | 6.71B | 5.78B | 4.45B | 3.63B |
Total Debt | 940.00M | 925.00M | 909.00M | 941.00M | 979.07M | 1.03B |
Total Liabilities | 7.94B | 7.20B | 7.89B | 7.13B | 6.96B | 6.79B |
Stockholders Equity | 21.82B | 22.26B | 21.35B | 19.49B | 18.75B | 18.49B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 501.00M | 1.43B | 1.49B | 1.12B | 348.33M |
Operating Cash Flow | 0.00 | 1.40B | 1.99B | 1.73B | 1.58B | 1.72B |
Investing Cash Flow | 0.00 | -1.12B | -520.00M | -103.00M | -457.15M | -1.02B |
Financing Cash Flow | 0.00 | -622.00M | -672.00M | -369.00M | -363.55M | -395.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥8.22B | 9.90 | 4.45% | 2.53% | -20.37% | ||
57 Neutral | £2.58B | 5.09 | -9.48% | 4.35% | 5.28% | -6.27% | |
― | €167.56M | 6.04 | 4.96% | 2.31% | ― | ― | |
75 Outperform | ¥22.30B | 12.22 | 4.19% | 2.95% | -53.11% | ||
72 Outperform | ¥44.53B | 12.62 | 3.09% | 9.57% | -20.99% | ||
66 Neutral | ¥7.31B | 9.90 | 2.07% | 2.20% | 28.34% | ||
49 Neutral | ¥3.73B | 106.00 | ― | 6.26% | -31.63% |